{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:01:21Z","timestamp":1780124481365,"version":"3.54.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07008-z","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:25:19Z","timestamp":1777645519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The gut microbiota and kawasaki disease: exploring the role of microbial dysbiosis and metabolites in pathogenesis and therapeutics"],"prefix":"10.1007","volume":"185","author":[{"given":"Amin","family":"Mohsenzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Mohsenzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammadhosein","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaddeseh","family":"Sheikhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita Hosseini","family":"Zabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hastisadat","family":"Mirheidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"17","key":"7008_CR1","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927\u2013e999","journal-title":"Circulation"},{"issue":"6","key":"7008_CR2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00431-025-06211-8","volume":"184","author":"M Alfalasi","year":"2025","unstructured":"Alfalasi M, Snobar R, Shaalan I, Alkhaaldi A, Khawaja K, Aldhanhani H et al (2025) Kawasaki disease in the pre- and post-COVID-19 era: shifts in patterns and outcomes from a multi-center study. Eur J Pediatr 184(6):367","journal-title":"Eur J Pediatr"},{"key":"7008_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218110","author":"A Ravelli","year":"2020","unstructured":"Ravelli A, Martini A (2020) Kawasaki disease or Kawasaki syndrome? Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218110","journal-title":"Ann Rheum Dis"},{"issue":"9433","key":"7008_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","volume":"364","author":"JC Burns","year":"2004","unstructured":"Burns JC, Glod\u00e9 MP (2004) Kawasaki syndrome. Lancet 364(9433):533\u2013544","journal-title":"Lancet"},{"issue":"6","key":"7008_CR5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/0961203313501401","volume":"23","author":"SM Vieira","year":"2014","unstructured":"Vieira SM, Pagovich OE, Kriegel MA (2014) Diet, microbiota and autoimmune diseases. Lupus 23(6):518\u2013526","journal-title":"Lupus"},{"key":"7008_CR6","doi-asserted-by":"crossref","unstructured":"Maciel-Fiuza MF, Muller GC, Campos DMS, do Socorro Silva Costa P, Peruzzo J, Bonamigo RR, et al. Role of gut microbiota in infectious and inflammatory diseases. Frontiers in Microbiology. 2023;Volume 14 - 2023.","DOI":"10.3389\/fmicb.2023.1098386"},{"key":"7008_CR7","doi-asserted-by":"crossref","unstructured":"Tao E, Lang D. Unraveling the gut: the pivotal role of intestinal mechanisms in Kawasaki disease pathogenesis. Frontiers in Immunology. 2024;Volume 15 - 2024.","DOI":"10.3389\/fimmu.2024.1496293"},{"issue":"4","key":"7008_CR8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/17460913.2025.2469432","volume":"20","author":"Q Yang","year":"2025","unstructured":"Yang Q, Kang Y, Tang W, Li M, Zhao C (2025) Interplay of gut microbiota in Kawasaki disease: role of gut microbiota and potential treatment strategies. Future Microbiol 20(4):357\u2013369","journal-title":"Future Microbiol"},{"issue":"3","key":"7008_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/ATVBAHA.124.321201","volume":"45","author":"PK Jena","year":"2025","unstructured":"Jena PK, Arditi M, Noval Rivas M (2025) Gut microbiota alterations in patients with Kawasaki disease. Arterioscler Thromb Vasc Biol 45(3):345\u2013358","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"7008_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/1756-185X.13218","volume":"21","author":"Y Onouchi","year":"2018","unstructured":"Onouchi Y (2018) The genetics of Kawasaki disease. Int J Rheum Dis 21(1):26\u201330","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"7008_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2188\/jea.JE20110131","volume":"22","author":"R Uehara","year":"2012","unstructured":"Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22(2):79\u201385","journal-title":"J Epidemiol"},{"issue":"6","key":"7008_CR12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/INF.0b013e3181cf8705","volume":"29","author":"RC Holman","year":"2010","unstructured":"Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB (2010) Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 29(6):483\u2013488","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"7008_CR13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3345\/kjp.2017.60.7.216","volume":"60","author":"JS Jun","year":"2017","unstructured":"Jun JS, Jung YK, Lee DW (2017) Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease. Korean J Pediatr 60(7):216","journal-title":"Korean J Pediatr"},{"issue":"4","key":"7008_CR14","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1158\/1535-7163.MCT-06-0677","volume":"6","author":"M Ben-Shoshan","year":"2007","unstructured":"Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ (2007) 1\u03b1, 25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1\/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther 6(4):1433\u20131439","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"7008_CR15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00431-014-2346-y","volume":"173","author":"Y-L Chen","year":"2014","unstructured":"Chen Y-L, Wang J-L, Li W-Q (2014) Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3. Eur J Pediatr 173(11):1467\u20131471","journal-title":"Eur J Pediatr"},{"issue":"1","key":"7008_CR16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, De Vries VC, Wasiuk A, Guo Y, Noelle RJ (2009) Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev 229(1):152\u2013172","journal-title":"Immunol Rev"},{"issue":"2","key":"7008_CR17","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1542\/peds.111.2.e140","volume":"111","author":"C-L Wang","year":"2003","unstructured":"Wang C-L, Wu Y-T, Liu C-A, Lin M-W, Lee C-J, Huang L-T et al (2003) Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 111(2):e140\u2013e147","journal-title":"Pediatrics"},{"issue":"7","key":"7008_CR18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0161-5890(03)00155-X","volume":"40","author":"MW Turner","year":"2003","unstructured":"Turner MW (2003) The role of mannose-binding lectin in health and disease. Mol Immunol 40(7):423\u2013429","journal-title":"Mol Immunol"},{"issue":"1","key":"7008_CR19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.21529","volume":"54","author":"MH Biezeveld","year":"2006","unstructured":"Biezeveld MH, Geissler J, Weverling GJ, Kuipers IM, Lam J, Ottenkamp J et al (2006) Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 54(1):369\u2013376","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"4","key":"7008_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1756-185X.2009.01428.x","volume":"12","author":"S Sato","year":"2009","unstructured":"Sato S, Kawashima H, Kashiwagi Y, Fujioka T, Takekuma K, Hoshika A (2009) Association of mannose-binding lectin gene polymorphisms with Kawasaki disease in the Japanese. Int J Rheum Dis 12(4):307\u2013310","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"7008_CR21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/apa.13773","volume":"106","author":"D Sudo","year":"2017","unstructured":"Sudo D, Nakamura Y (2017) Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30 years. Acta Paediatr 106(5):796\u2013800","journal-title":"Acta Paediatr"},{"issue":"7415","key":"7008_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11551","volume":"489","author":"CL Maynard","year":"2012","unstructured":"Maynard CL, Elson CO, Hatton RD, Weaver CT (2012) Reciprocal interactions of the intestinal microbiota and immune system. Nature 489(7415):231\u2013241","journal-title":"Nature"},{"issue":"1","key":"7008_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-016-0104-6","volume":"14","author":"M Arvonen","year":"2016","unstructured":"Arvonen M, Berntson L, Pokka T, Karttunen TJ, V\u00e4h\u00e4salo P, Stoll ML (2016) Gut microbiota-host interactions and juvenile idiopathic arthritis. Pediatr Rheumatol Online J 14(1):1\u20139","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"7008_CR24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.chom.2018.05.013","volume":"23","author":"A Milshteyn","year":"2018","unstructured":"Milshteyn A, Colosimo DA, Brady SF (2018) Accessing bioactive natural products from the human microbiome. Cell Host Microbe 23(6):725\u2013736","journal-title":"Cell Host Microbe"},{"key":"7008_CR25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01616","volume":"11","author":"K Kaneko","year":"2020","unstructured":"Kaneko K, Akagawa S, Akagawa Y, Kimata T, Tsuji S (2020) Our evolving understanding of Kawasaki disease pathogenesis: role of the gut microbiota. Front Immunol 11:1616","journal-title":"Front Immunol"},{"key":"7008_CR26","doi-asserted-by":"crossref","unstructured":"Esposito S, Polinori I, Rigante D. The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome. Frontiers in Pediatrics. 2019;Volume 7 - 2019.","DOI":"10.3389\/fped.2019.00124"},{"issue":"23","key":"7008_CR27","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1042\/CS20201224","volume":"134","author":"Z Guan","year":"2020","unstructured":"Guan Z, Jia J, Zhang C, Sun T, Zhang W, Yuan W et al (2020) Gut microbiome dysbiosis alleviates the progression of osteoarthritis in mice. Clin Sci 134(23):3159\u20133174","journal-title":"Clin Sci"},{"issue":"1","key":"7008_CR28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/15548627.2019.1635384","volume":"16","author":"A Larabi","year":"2020","unstructured":"Larabi A, Barnich N, Nguyen HTT (2020) New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD. Autophagy 16(1):38\u201351","journal-title":"Autophagy"},{"issue":"2","key":"7008_CR29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000447639","volume":"170","author":"A Hassidim","year":"2016","unstructured":"Hassidim A, Merdler I, Chorin O, Merdler-Rabinowicz R, Dallal I, Perlman M et al (2016) Atopic predilection among Kawasaki disease patients: a cross-sectional study of 1,187,757 teenagers. Int Arch Allergy Immunol 170(2):92\u201396","journal-title":"Int Arch Allergy Immunol"},{"key":"7008_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/605123","author":"PY Woon","year":"2013","unstructured":"Woon PY, Chang WC, Liang C-C, Hsu CH, Klahan S, Huang Y-H et al (2013) Increased risk of atopic dermatitis in preschool children with Kawasaki disease: a population-based study in Taiwan. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2013\/605123","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"7008_CR31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jpeds.2013.03.068","volume":"163","author":"C-Y Hwang","year":"2013","unstructured":"Hwang C-Y, Hwang Y-Y, Chen Y-J, Chen C-C, Lin M-W, Chen T-J et al (2013) Atopic diathesis in patients with Kawasaki disease. J Pediatr 163(3):811\u2013815","journal-title":"J Pediatr"},{"issue":"3","key":"7008_CR32","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12855","volume":"91","author":"M Salameh","year":"2020","unstructured":"Salameh M, Burney Z, Mhaimeed N, Laswi I, Yousri NA, Bendriss G et al (2020) The role of gut microbiota in atopic asthma and allergy, implications in the understanding of disease pathogenesis. Scand J Immunol 91(3):e12855","journal-title":"Scand J Immunol"},{"key":"7008_CR33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1268453","volume":"14","author":"Y Teramoto","year":"2023","unstructured":"Teramoto Y, Akagawa S, Hori SI, Tsuji S, Higasa K, Kaneko K (2023) Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease. Front Immunol 14:1268453","journal-title":"Front Immunol"},{"issue":"4","key":"7008_CR34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2567.2009.03135.x","volume":"128","author":"S Nagata","year":"2009","unstructured":"Nagata S, Yamashiro Y, Ohtsuka Y, Shimizu T, Sakurai Y, Misawa S et al (2009) Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease. Immunology 128(4):511\u2013520","journal-title":"Immunology"},{"key":"7008_CR35","doi-asserted-by":"crossref","unstructured":"Fukazawa M Jr, Fukazawa M, Nanishi E, Nishio H, Ichihara K, Ohga S (2020) Previous antibiotic use and the development of Kawasaki disease: a matched pair case-control study. Pediatr Int 62(9):1044\u20131048","DOI":"10.1111\/ped.14255"},{"key":"7008_CR36","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3389\/fmicb.2015.00824","volume":"6","author":"A Kinumaki","year":"2015","unstructured":"Kinumaki A, Sekizuka T, Hamada H, Kato K, Yamashita A, Kuroda M (2015) Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis. Front Microbiol 6:824","journal-title":"Front Microbiol"},{"key":"7008_CR37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett B (2011) Intestinal flora phosphatidylcholine metabolism contributes to cardiovascular disease. Nature 472:57\u201363","journal-title":"Nature"},{"key":"7008_CR38","doi-asserted-by":"crossref","unstructured":"Koeth R, Wang Z, Levison B, Buffa J, Org E, Sheehy B, et al. Hazen. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med: SL. 2013.","DOI":"10.1038\/nm.3145"},{"issue":"5","key":"7008_CR39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"I Nemet","year":"2020","unstructured":"Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM et al (2020) A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 180(5):862\u201377. e22","journal-title":"Cell"},{"issue":"2","key":"7008_CR40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF02072479","volume":"152","author":"T Akiyama","year":"1993","unstructured":"Akiyama T, Yashiro K (1993) Probable role ofStreptococcus pyogenes in Kawasaki disease. Eur J Pediatr 152(2):82\u201392","journal-title":"Eur J Pediatr"},{"issue":"3","key":"7008_CR41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/598638","volume":"29","author":"M Hall","year":"1999","unstructured":"Hall M, Hoyt L, Ferrieri P, Schlievert PM, Jenson HB (1999) Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. Clin Infect Dis 29(3):586\u2013589","journal-title":"Clin Infect Dis"},{"issue":"8","key":"7008_CR42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s004310100775","volume":"160","author":"A Ferwerda","year":"2001","unstructured":"Ferwerda A, Moll HA, de Groot R (2001) Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr 160(8):483\u2013491","journal-title":"Eur J Pediatr"},{"issue":"1","key":"7008_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2013.04.004","volume":"67","author":"N Principi","year":"2013","unstructured":"Principi N, Rigante D, Esposito S (2013) The role of infection in Kawasaki syndrome. J Infect 67(1):1\u201310","journal-title":"J Infect"},{"issue":"4","key":"7008_CR44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1203\/00006450-199604000-00010","volume":"39","author":"Y Yamashiro","year":"1996","unstructured":"Yamashiro Y, Nagata S, Ohtsuka Y, Oguchi S, Shimizu T (1996) Microbiologic studies on the small intestine in Kawasaki disease. Pediatr Res 39(4):622\u2013624","journal-title":"Pediatr Res"},{"issue":"1","key":"7008_CR45","doi-asserted-by":"crossref","first-page":"14525","DOI":"10.1038\/s41598-020-71371-6","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Yue Y, Wang L, Deng Z, Yuan Y, Zhao M et al (2020) Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease. Sci Rep 10(1):14525","journal-title":"Sci Rep"},{"issue":"6","key":"7008_CR46","volume":"12","author":"H Yan","year":"2017","unstructured":"Yan H, Ajuwon KM (2017) Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. PLoS One 12(6):e0179586","journal-title":"PLoS One"},{"key":"7008_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2024.104912","volume":"408","author":"J Bakshi","year":"2025","unstructured":"Bakshi J, Mishra KP (2025) Sodium butyrate prevents lipopolysaccharide induced inflammation and restores the expression of tight junction protein in human epithelial Caco-2 cells. Cell Immunol 408:104912","journal-title":"Cell Immunol"},{"key":"7008_CR48","doi-asserted-by":"crossref","first-page":"1124118","DOI":"10.3389\/fimmu.2023.1124118","volume":"14","author":"F Wang","year":"2023","unstructured":"Wang F, Qian F, Zhang Q, Zhao J, Cen J, Zhang J et al (2023) The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease. Front Immunol 14:1124118","journal-title":"Front Immunol"},{"issue":"24","key":"7008_CR49","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1111\/febs.16945","volume":"290","author":"T Inamoto","year":"2023","unstructured":"Inamoto T, Furuta K, Han C, Uneme M, Kano T, Ishikawa K et al (2023) Short-chain fatty acids stimulate dendrite elongation in dendritic cells by inhibiting histone deacetylase. Febs j 290(24):5794\u20135810","journal-title":"Febs j"},{"issue":"2","key":"7008_CR50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G et al (2013) Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39(2):372\u2013385","journal-title":"Immunity"},{"issue":"7361","key":"7008_CR51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/476393a","volume":"476","author":"M Blaser","year":"2011","unstructured":"Blaser M (2011) Stop the killing of beneficial bacteria. Nature 476(7361):393\u2013394","journal-title":"Nature"},{"issue":"3","key":"7008_CR52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009836","volume":"5","author":"HE Jakobsson","year":"2010","unstructured":"Jakobsson HE, Jernberg C, Andersson AF, Sj\u00f6lund-Karlsson M, Jansson JK, Engstrand L (2010) Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 5(3):e9836","journal-title":"PLoS ONE"},{"issue":"11","key":"7008_CR53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060280","volume":"6","author":"L Dethlefsen","year":"2008","unstructured":"Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6(11):e280","journal-title":"PLoS Biol"},{"issue":"7","key":"7008_CR54","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/INF.0000000000004335","volume":"43","author":"TH Kim","year":"2024","unstructured":"Kim TH, Shin JS, Kim SY, Kim J (2024) Association of previous antibiotics use and Kawasaki disease: a cohort study of 106,908 patients. Pediatr Infect Dis J 43(7):643\u2013650","journal-title":"Pediatr Infect Dis J"},{"key":"7008_CR55","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1467288","volume":"12","author":"H Ansai","year":"2024","unstructured":"Ansai H, Yamada M, Masuda H, Imadome KI, Yashiro M, Noval Rivas M et al (2024) Association of recent antibiotic exposure and coronary artery lesions in Kawasaki disease: nationwide study. Front Pediatr 12:1467288","journal-title":"Front Pediatr"},{"key":"7008_CR56","first-page":"6660407","volume":"2021","author":"W Li","year":"2021","unstructured":"Li W, He X, Zhang L, Wang Z, Wang Y, Lin H et al (2021) A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better? Cardiovasc Ther 2021:6660407","journal-title":"Cardiovasc Ther"},{"key":"7008_CR57","doi-asserted-by":"crossref","first-page":"1715478","DOI":"10.3389\/fmicb.2025.1715478","volume":"16","author":"H Chen","year":"2025","unstructured":"Chen H, Liu H, Qiao L, Liu Y, Yu D, Wang Z et al (2025) The characteristics of the gut microbiota in patients with Kawasaki disease: a systematic review. Front Microbiol 16:1715478","journal-title":"Front Microbiol"},{"issue":"137","key":"7008_CR58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004183","volume":"4","author":"KP Lemon","year":"2012","unstructured":"Lemon KP, Armitage GC, Relman DA, Fischbach MA (2012) Microbiota-targeted therapies: An ecological perspective. Sci Transl Med 4(137):137rv5","journal-title":"Sci Transl Med"},{"key":"7008_CR59","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101599","volume":"59","author":"F Strati","year":"2022","unstructured":"Strati F, Lattanzi G, Amoroso C, Facciotti F (2022) Microbiota-targeted therapies in inflammation resolution. Semin Immunol 59:101599","journal-title":"Semin Immunol"},{"key":"7008_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13142338","author":"PL Nadig","year":"2023","unstructured":"Nadig PL, Joshi V, Pilania RK, Kumrah R, Kabeerdoss J, Sharma S et al (2023) Intravenous immunoglobulin in Kawasaki disease-evolution and pathogenic mechanisms. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics13142338","journal-title":"Diagnostics"},{"issue":"8","key":"7008_CR61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237189","volume":"15","author":"C Ramakrishna","year":"2020","unstructured":"Ramakrishna C, Mendonca S, Ruegger PM, Kim JH, Borneman J, Cantin EM (2020) Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis. PLoS One 15(8):e0237189","journal-title":"PLoS One"},{"issue":"11","key":"7008_CR62","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1111\/ene.15679","volume":"30","author":"MKR Sva\u010dina","year":"2023","unstructured":"Sva\u010dina MKR, Sprenger-Sva\u010dina A, Tsakmaklis A, R\u00fcb AM, Klein I, W\u00fcstenberg H et al (2023) The gut microbiome in intravenous immunoglobulin-treated chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 30(11):3551\u20133556","journal-title":"Eur J Neurol"},{"key":"7008_CR63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jare.2022.06.002","volume":"46","author":"Z Wang","year":"2023","unstructured":"Wang Z, Xiao H, Dong J, Li Y, Wang B, Chen Z et al (2023) Sexual dimorphism in gut microbiota dictates therapeutic efficacy of intravenous immunoglobulin on radiotherapy complications. J Adv Res 46:123\u2013133","journal-title":"J Adv Res"},{"key":"7008_CR64","volume":"15","author":"L Han","year":"2024","unstructured":"Han L, Liu X, Lan Y, Hua Y, Fan Z, Li Y (2024) Metagenomic analysis demonstrates distinct changes in the gut microbiome of Kawasaki diseases children. Front Immunol 15:1416185","journal-title":"Front Immunol"},{"issue":"3","key":"7008_CR65","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jamapediatrics.2018.3307","volume":"173","author":"T Sosa","year":"2019","unstructured":"Sosa T, Brower L, Divanovic A (2019) Diagnosis and management of Kawasaki disease. JAMA Pediatr 173(3):278\u2013279","journal-title":"JAMA Pediatr"},{"issue":"1","key":"7008_CR66","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00431-023-05302-8","volume":"183","author":"T Suzuki","year":"2024","unstructured":"Suzuki T, Michihata N, Hashimoto Y, Yoshikawa T, Saito K, Matsui H et al (2024) Association between aspirin dose and outcomes in patients with acute Kawasaki disease: a nationwide retrospective cohort study in Japan. Eur J Pediatr 183(1):415\u2013424","journal-title":"Eur J Pediatr"},{"issue":"2","key":"7008_CR67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.chom.2023.12.015","volume":"32","author":"T Li","year":"2024","unstructured":"Li T, Ding N, Guo H, Hua R, Lin Z, Tian H et al (2024) A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage. Cell Host Microbe 32(2):191-208.e9","journal-title":"Cell Host Microbe"},{"key":"7008_CR68","volume":"2021","author":"T Chi","year":"2021","unstructured":"Chi T, Zhao Q, Wang P (2021) Fecal 16S rRNA gene sequencing analysis of changes in the gut microbiota of rats with low-dose aspirin-related intestinal injury. Biomed Res Int 2021:8848686","journal-title":"Biomed Res Int"},{"key":"7008_CR69","volume":"120","author":"Z Bai","year":"2023","unstructured":"Bai Z, Liu Y, Zhao Y, Yan R, Yang L, Ma H et al (2023) Aspirin ameliorates atherosclerotic immuno-inflammation through regulating the Treg\/Th17 axis and CD39-CD73 adenosine signaling via remodeling the gut microbiota in ApoE(-\/-) mice. Int Immunopharmacol 120:110296","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"7008_CR70","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12887-019-1504-9","volume":"19","author":"H Chan","year":"2019","unstructured":"Chan H, Chi H, You H, Wang M, Zhang G, Yang H et al (2019) Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease. BMC Pediatr 19(1):158","journal-title":"BMC Pediatr"},{"issue":"2","key":"7008_CR71","volume":"15","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Guan G, Liu J, Hu W, Jin P (2024) Gut microbiota dysbiosis and decreased levels of acetic and propionic acid participate in glucocorticoid-induced glycolipid metabolism disorder. mBio 15(2):e0294323","journal-title":"mBio"},{"key":"7008_CR72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lfs.2017.11.049","volume":"192","author":"T Wu","year":"2018","unstructured":"Wu T, Yang L, Jiang J, Ni Y, Zhu J, Zheng X et al (2018) Chronic glucocorticoid treatment induced circadian clock disorder leads to lipid metabolism and gut microbiota alterations in rats. Life Sci 192:173\u2013182","journal-title":"Life Sci"},{"issue":"1","key":"7008_CR73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s44161-022-00197-4","volume":"2","author":"HA Jama","year":"2023","unstructured":"Jama HA, Rhys-Jones D, Nakai M, Yao CK, Climie RE, Sata Y et al (2023) Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial. Nat Cardiovasc Res 2(1):35\u201343","journal-title":"Nat Cardiovasc Res"},{"issue":"2","key":"7008_CR74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/07388551.2014.953443","volume":"36","author":"DA Flores-Maltos","year":"2016","unstructured":"Flores-Maltos DA, Mussatto SI, Contreras-Esquivel JC, Rodr\u00edguez-Herrera R, Teixeira JA, Aguilar CN (2016) Biotechnological production and application of fructooligosaccharides. Crit Rev Biotechnol 36(2):259\u2013267","journal-title":"Crit Rev Biotechnol"},{"issue":"14","key":"7008_CR75","volume":"63","author":"S Zhang","year":"2019","unstructured":"Zhang S, Hu H, He W, Muhammad Z, Wang L, Liu F et al (2019) Regulatory roles of pectin oligosaccharides on immunoglobulin production in healthy mice mediated by gut microbiota. Mol Nutr Food Res 63(14):e1801363","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"7008_CR76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/17460913.2025.2469432","volume":"20","author":"Q Yang","year":"2025","unstructured":"Yang Q, Yaqing K, Wei T, Meng L, Zhao C (2025) Interplay of gut microbiota in Kawasaki disease: role of gut microbiota and potential treatment strategies. Future Microbiol 20(4):357\u2013369","journal-title":"Future Microbiol"},{"key":"7008_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116022","author":"P Chandrasekaran","year":"2024","unstructured":"Chandrasekaran P, Weiskirchen S, Weiskirchen R (2024) Effects of probiotics on gut microbiota: an overview. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25116022","journal-title":"Int J Mol Sci"},{"key":"7008_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071428","author":"GU Varela-Trinidad","year":"2022","unstructured":"Varela-Trinidad GU, Dom\u00ednguez-D\u00edaz C, Sol\u00f3rzano-Castanedo K, \u00cd\u00f1iguez-Guti\u00e9rrez L, Hern\u00e1ndez-Flores TJ, Fafutis-Morris M (2022) Probiotics: protecting our health from the gut. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10071428","journal-title":"Microorganisms"},{"issue":"10","key":"7008_CR79","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani PD, Depommier C, Derrien M, Everard A, de Vos WM (2022) Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat Rev Gastroenterol Hepatol 19(10):625\u2013637","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7008_CR80","first-page":"1","volume":"2021","author":"X He","year":"2021","unstructured":"He X, Zhao S, Li Y (2021) Faecalibacterium prausnitzii: a next-generation probiotic in gut disease improvement. Can J Infect Dis Med Microbiol 2021:1\u201310","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"8","key":"7008_CR81","first-page":"e53","volume":"136","author":"PK Jena","year":"2025","unstructured":"Jena PK, Wakita D, Gomez AC, Carvalho TT, Atici AE, Aubuchon E et al (2025) Intestinal Microbiota Contributes to the Development of Cardiovascular Inflammation and Vasculitis in Mice. Circ Res 136(8):e53\u2013e72","journal-title":"Circ Res"},{"issue":"22","key":"7008_CR82","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB et al (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110(22):9066\u20139071","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"7008_CR83","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","volume":"23","author":"H Plovier","year":"2017","unstructured":"Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L et al (2017) A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 23(1):107\u2013113","journal-title":"Nat Med"},{"key":"7008_CR84","doi-asserted-by":"crossref","unstructured":"He X, Bai Y, Zhou H, Wu K. Akkermansia muciniphila Alters Gut Microbiota and Immune System to Improve Cardiovascular Diseases in Murine Model. Frontiers in Microbiology. 2022;Volume 13 - 2022.","DOI":"10.3389\/fmicb.2022.906920"},{"issue":"10","key":"7008_CR85","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00172-24","volume":"92","author":"S Wang","year":"2024","unstructured":"Wang S, Shi H, Cheng Y, Jiang L, Lou Y, Kumar M et al (2024) Akkermansia muciniphila alleviates abdominal aortic aneurysms via restoring CITED2 activated by EPAS1. Infect Immun 92(10):e0017224","journal-title":"Infect Immun"},{"issue":"24","key":"7008_CR86","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.115.019645","volume":"133","author":"J Li","year":"2016","unstructured":"Li J, Lin S, Vanhoutte PM, Woo CW, Xu A (2016) Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe-\/- mice. Circulation 133(24):2434\u20132446","journal-title":"Circulation"},{"issue":"5","key":"7008_CR87","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","volume":"156","author":"CL Hvas","year":"2019","unstructured":"Hvas CL, Dahl J\u00f8rgensen SM, J\u00f8rgensen SP, Storgaard M, Lemming L, Hansen MM et al (2019) Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. Gastroenterology 156(5):1324\u201332.e3","journal-title":"Gastroenterology"},{"issue":"4","key":"7008_CR88","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cgh.2020.12.004","volume":"20","author":"GK Dawwas","year":"2022","unstructured":"Dawwas GK, Brensinger CM, Vajravelu RK, Wu Q, Kelly CR, Laine L et al (2022) Long-term outcomes following multiply recurrent Clostridioides difficile infection and fecal microbiota transplantation. Clin Gastroenterol Hepatol 20(4):806\u201316.e6","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"7008_CR89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3748\/wjg.v24.i1.5","volume":"24","author":"ZH Shen","year":"2018","unstructured":"Shen ZH, Zhu CX, Quan YS, Yang ZY, Wu S, Luo WW et al (2018) Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol 24(1):5\u201314","journal-title":"World J Gastroenterol"},{"issue":"21","key":"7008_CR90","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH et al (2019) Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med 381(21):2043\u201350","journal-title":"N Engl J Med"},{"issue":"4","key":"7008_CR91","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","volume":"66","author":"G Cammarota","year":"2017","unstructured":"Cammarota G, Ianiro G, Tilg H, Rajili\u0107-Stojanovi\u0107 M, Kump P, Satokari R et al (2017) European consensus conference on faecal microbiota transplantation in clinical practice. Gut 66(4):569\u2013580","journal-title":"Gut"},{"key":"7008_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/nu15061539","author":"L Zhang","year":"2023","unstructured":"Zhang L, Liu Y, Wang X, Zhang X (2023) Physical exercise and diet: regulation of gut microbiota to prevent and treat metabolic disorders to maintain health. Nutrients. https:\/\/doi.org\/10.3390\/nu15061539","journal-title":"Nutrients"},{"issue":"7","key":"7008_CR93","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1535370218763760","volume":"243","author":"Y Lyu","year":"2018","unstructured":"Lyu Y, Wu L, Wang F, Shen X, Lin D (2018) Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis. Exp Biol Med (Maywood) 243(7):613\u2013620","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"7008_CR94","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/pr.2012.168","volume":"73","author":"MA Portman","year":"2013","unstructured":"Portman MA (2013) Kawasaki disease and soy: potential role for isoflavone interaction with Fc\u03b3 receptors. Pediatr Res 73(2):130\u2013134","journal-title":"Pediatr Res"},{"issue":"7","key":"7008_CR95","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S et al (2019) Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med 25(7):1096\u20131103","journal-title":"Nat Med"},{"issue":"2","key":"7008_CR96","doi-asserted-by":"crossref","first-page":"E47","DOI":"10.3314\/mmj.16-00014","volume":"58","author":"W Sato","year":"2017","unstructured":"Sato W, Ishibashi KI, Yamanaka D, Adachi Y, Ohno N (2017) Effects of natural and chemically defined nutrients on Candida albicans water-soluble fraction (CAWS) vasculitis in mice. Med Mycol J 58(2):E47-e62","journal-title":"Med Mycol J"},{"issue":"2","key":"7008_CR97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.12938\/bmfh.18-027","volume":"38","author":"TA Muhomah","year":"2019","unstructured":"Muhomah TA, Nishino N, Katsumata E, Haoming W, Tsuruta T (2019) High-fat diet reduces the level of secretory immunoglobulin A coating of commensal gut microbiota. Biosci Microbiota Food Health 38(2):55\u201364","journal-title":"Biosci Microbiota Food Health"},{"issue":"3","key":"7008_CR98","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3164\/jcbn.15-15","volume":"57","author":"T Taira","year":"2015","unstructured":"Taira T, Yamaguchi S, Takahashi A, Okazaki Y, Yamaguchi A, Sakaguchi H et al (2015) Dietary polyphenols increase fecal mucin and immunoglobulin A and ameliorate the disturbance in gut microbiota caused by a high fat diet. J Clin Biochem Nutr 57(3):212\u2013216","journal-title":"J Clin Biochem Nutr"},{"issue":"3","key":"7008_CR99","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/19490976.2017.1290757","volume":"8","author":"AR Weingarden","year":"2017","unstructured":"Weingarden AR, Vaughn BP (2017) Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes 8(3):238\u2013252","journal-title":"Gut Microbes"},{"issue":"11","key":"7008_CR100","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14157","volume":"33","author":"M El-Salhy","year":"2021","unstructured":"El-Salhy M, Hausken T, Hatlebakk JG (2021) Current status of fecal microbiota transplantation for irritable bowel syndrome. Neurogastroenterol Motil 33(11):e14157","journal-title":"Neurogastroenterol Motil"},{"key":"7008_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030608","author":"TS Abujamel","year":"2022","unstructured":"Abujamel TS, Al-Otaibi NM, Abuaish S, AlHarbi RH, Assas MB, Alzahrani SA et al (2022) Different alterations in gut microbiota between Bifidobacterium longum and fecal microbiota transplantation treatments in propionic acid rat model of autism. Nutrients. https:\/\/doi.org\/10.3390\/nu14030608","journal-title":"Nutrients"},{"key":"7008_CR102","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102844","volume":"130","author":"C Huang","year":"2022","unstructured":"Huang C, Yi P, Zhu M, Zhou W, Zhang B, Yi X et al (2022) Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial. J Autoimmun 130:102844","journal-title":"J Autoimmun"},{"issue":"3","key":"7008_CR103","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s10753-024-02233-w","volume":"48","author":"Y Lai","year":"2025","unstructured":"Lai Y, Qiu R, Zhou J, Ren L, Qu Y, Zhang G (2025) Fecal microbiota transplantation alleviates airway inflammation in asthmatic rats by increasing the level of short-chain fatty acids in the intestine. Inflammation 48(3):1538\u20131552","journal-title":"Inflammation"},{"issue":"1","key":"7008_CR104","volume":"21","author":"X Li","year":"2025","unstructured":"Li X, Ding Q, Wan X, Wu Q, Ye S, Lou Y (2025) Fecal microbiota transplantation attenuates Alzheimer\u2019s disease symptoms in APP\/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-\u03baB signaling pathway-mediated inflammation. Behav Brain Funct 21(1):2","journal-title":"Behav Brain Funct"},{"key":"7008_CR105","doi-asserted-by":"publisher","unstructured":"Yu R, Zhang H, Chen R, Lin Y, Xu J, Fang Z et al (2025) Fecal microbiota transplantation from methionine-restricted diet mouse donors improves Alzheimer\u2019s learning and memory abilities through short-chain fatty acids. Foods. https:\/\/doi.org\/10.3390\/foods14010101","DOI":"10.3390\/foods14010101"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07008-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07008-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07008-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:03:01Z","timestamp":1780120981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07008-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":105,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["7008"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07008-z","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that AI-assisted copy editing (using ChatGPT 5.1) was used exclusively to improve human-generated text for readability and style and to ensure that the manuscript is free of errors in grammar, spelling, punctuation, and tone. AI assistance was limited to wording and formatting refinements and did not involve generative editorial work or autonomous content creation. The authors retain full responsibility for the final content and confirm that all edits accurately reflect their original work and intentions. In addition, no data or images were generated using AI-powered tools.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of the application of AI"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}